Fundraising Fox

BioCircuit Technologies

Atlanta, US · Founded 2016 · Georgia corporation · 46 employees on LinkedIn · 1 known investors

BioCircuit Technologies develops advanced medical devices for tissue repair and neuromodulation, with specialization in biomaterials, nitinol design, and bioelectronics. The company serves surgical teams with products like Nerve Tape®, a sutureless device for nerve repair.

BiotechDeep TechMedical Devices

Founders & leadership

TO
Thomas O'BrienExecutive

Board

MJMichelle Jarrard
Michelle Jarrardin𝕏CEOManaging Director at GRA Venture
JN
James NahirnyBoard director

Investors · 1

GRA Venture✓ verifiedGeorgia

Reported raises · per SEC filings

Form D private placements

$13.7M disclosed across 3 rounds · 2019–2022

▶$9MraisedOct 2022 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michelle JarrardExecutive Officer, Director
  • James NahirnyDirector
  • Michael MastersDirector
  • Thomas O'BrienDirector
Offering amount
$9M
Amount sold
$9M
First sale
Sep 2022
Incorporated
Corporation, Georgia
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedApr 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James NahirnyDirector
  • Michael MastersDirector
  • Thomas O'BrienDirector
  • Michelle JarrardExecutive Officer, Director
Offering amount
$3.1M
Amount sold
$3.1M
First sale
Apr 2021
Incorporated
Corporation, Georgia, 2016
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedApr 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michelle JarrardExecutive Officer, Director
  • James NahirnyDirector
  • Thomas O'BrienExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
First sale
May 2019
Incorporated
Corporation, Georgia, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Read the Press Release25 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Axogeninc15 shared keywordsAxogen develops surgical technologies and solutions for peripheral nerve repair procedures across various anatomical locations. The company serves surgical specialists and healthcare providers seeking to establish nerve function restoration as a standard treatment approach.

Companies competing with BioCircuit Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1.9M
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$1.9M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

NIH Awards BioCircuit Technologies $3M to Expand Nerve Tape®prweb.com · Nov 2024Group - NanoBioSensors & Systems Laboratorynanoscience.ucf.edu · Apr 2023Richmond Inno - VCU spinout BioCircuit Technologies raises $9M to bring Nerve Tape to marketbizjournals.com · Nov 2022Atlanta medical device startup BioCircuit Technologies raises $9 million for nerve repair devices - Atlanta Business Chroniclebizjournals.com · Oct 2022

Frequently asked questions

What does BioCircuit Technologies do?
BioCircuit Technologies develops advanced medical devices for tissue repair and neuromodulation, with specialization in biomaterials, nitinol design, and bioelectronics. The company serves surgical teams with products like Nerve Tape®, a sutureless device for nerve repair.
Who are BioCircuit Technologies's investors?
BioCircuit Technologies's investors include GRA Venture.
How much funding has BioCircuit Technologies raised?
BioCircuit Technologies has disclosed $13.7M raised across 3 rounds.
Where is BioCircuit Technologies headquartered?
BioCircuit Technologies is headquartered in Atlanta, US.